علاج قلة الصفيحات الحادة الناجمة عن الهيبارين لدى المرضى الخاضعين للعلاج بالبدائل الكلوية

References

DOI: 10.1182/bloodadvances.2018024489

• In patients with acute HIT who are receiving renal replacement therapy and require anticoagulation to prevent thrombosis of the dialysis circuitry, the ASH guideline panel suggests treatment with argatroban, danaparoid, or bivalirudin rather than other non-heparin anticoagulants (conditional recommendation; very low certainty in the evidence about effects).